Circulating Tumor DNA in a Breast Cancer Patient's Plasma Represents Driver Alterations in the Tumor Tissue
Tumor tissues from biopsies or surgery are major sources for the next generation sequencing (NGS) study, but these procedures are invasive and have limitation to overcome intratumor heterogeneity. Recent studies have shown that driver alterations in tumor tissues can be detected by liquid biopsy whi...
Saved in:
Main Authors: | Jieun Lee, Sung-Min Cho, Min Sung Kim, Sug Hyung Lee, Yeun-Jun Chung, Seung-Hyun Jung |
---|---|
Format: | Article |
Language: | English |
Published: |
BioMed Central
2017-03-01
|
Series: | Genomics & Informatics |
Subjects: | |
Online Access: | http://genominfo.org/upload/pdf/gni-15-48.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of circulating tumor DNA as a prognostic and predictive biomarker in BRAF V600E mutated colorectal cancer—results from the FIRE‐4.5 study
by: Susanne Klein‐Scory, et al.
Published: (2025-02-01) -
Circulating tumor DNA for surveillance in high-risk melanoma patients: a study protocol
by: Magnús P.B. Obinah, et al.
Published: (2025-02-01) -
Integration of circulating tumor DNA in biliary tract cancer: the emerging landscape
by: Joy A Awosika, et al.
Published: (2024-12-01) -
Early release of circulating tumor cells after transarterial chemoembolization hinders therapeutic response in patients with hepatocellular carcinoma
by: María L. Espejo-Cruz, et al.
Published: (2025-01-01) -
Detection of mutations in plasma cell-free DNA of colorectal cancer patients and comparison with cancer panel data for tissue samples of the same cancers
by: Suji Min, et al.
Published: (2019-11-01)